Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19
Authors
Keywords
SARS Covid 19, Specialized pro‑resolving mediators, Inflammation, Resolution
Journal
MEDICAL HYPOTHESES
Volume 145, Issue -, Pages 110340
Publisher
Elsevier BV
Online
2020-10-08
DOI
10.1016/j.mehy.2020.110340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The outbreak of COVID-19
- (2020) Yi-Chi Wu et al. Journal of the Chinese Medical Association
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
- (2020) Huan Han et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
- (2020) Songping Cui et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- 15-Epi-LXA4and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation
- (2020) Meriem Sekheri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
- (2020) Tao Wang et al. Lancet Haematology
- Immunothrombotic Dysregulation in COVID-19 Pneumonia is Associated with Respiratory Failure and Coagulopathy
- (2020) Leo Nicolai et al. CIRCULATION
- Resolvin D4 attenuates the severity of pathological thrombosis in mice
- (2019) Deya Cherpokova et al. BLOOD
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms
- (2017) Charles N. Serhan FASEB JOURNAL
- Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling
- (2016) Tarec K. Elajami et al. FASEB JOURNAL
- Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome
- (2015) Charles N. Serhan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza
- (2013) Masayuki Morita et al. CELL
- Targeting the “Cytokine Storm” for Therapeutic Benefit
- (2013) Riccardo V. D'Elia et al. Clinical and Vaccine Immunology
- Resolution phase lipid mediators of inflammation: agonists of resolution
- (2013) Charles N. Serhan et al. CURRENT OPINION IN PHARMACOLOGY
- Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
- (2013) I. Tabas et al. SCIENCE
- Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field
- (2012) Bengt Samuelsson JOURNAL OF BIOLOGICAL CHEMISTRY
- The acute respiratory distress syndrome
- (2012) Michael A. Matthay et al. JOURNAL OF CLINICAL INVESTIGATION
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Lethal Dissemination of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of Infection
- (2010) C. Cilloniz et al. JOURNAL OF VIROLOGY
- Lipoxins: resolutionary road
- (2009) Paola Maderna et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostaglandins, bioassay and inflammation
- (2006) R J Flower BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search